Antibody and ADC
Drug Discovery

From Novel Target Validation to Functional Therapeutics

We offer end-to-end support for monoclonal antibody (mAb) and antibody-drug conjugate (ADC) development through an integrated discovery platform and in vivo validation pipeline.

Monoclonal Antibody
Discovery

  • Humanized antibody mouse model (e.g., HuMab mice) for therapeutic mAb generation

  • Hybridoma and phage display services

  • Affinity maturation and epitope mapping

Antibody
Characterization

  • Binding kinetics (SPR, BLI), cross-reactivity, isotyping

  • Effector function assays: ADCC, CDC, apoptosis

In Vivo Antibody
Efficacy Models

  • Humanized mice + PDX for antibody validation

  • Immune checkpoint blockade and bispecific antibody testing

ADC Development
Support

  • Cytotoxic payload conjugation and linker optimization

  • Stability testing, PK/PD studies, and tissue distribution